Lifeist Wellness Inc. (LFST.V)
CAD 0.04
(0.0%)
CAD 0.04
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 9.94 Million CAD | 36.08% |
| 2022 | 7.3 Million CAD | -38.58% |
| 2021 | 11.89 Million CAD | 16.16% |
| 2020 | 10.23 Million CAD | -14.26% |
| 2019 | 11.94 Million CAD | 122.08% |
| 2018 | 5.37 Million CAD | 124.33% |
| 2017 | 2.39 Million CAD | 8.96% |
| 2016 | 2.19 Million CAD | 301.0% |
| 2015 | 548.62 Thousand CAD | 1287.47% |
| 2014 | 39.54 Thousand CAD | -3.94% |
| 2013 | 41.16 Thousand CAD | -33.77% |
| 2012 | 62.15 Thousand CAD | -51.83% |
| 2011 | 129.04 Thousand CAD | 829.85% |
| 2010 | 13.87 Thousand CAD | -94.66% |
| 2009 | 259.88 Thousand CAD | 59.01% |
| 2008 | 163.44 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 10.02 Million CAD | -17.48% |
| 2024 Q1 | 12.14 Million CAD | 22.15% |
| 2024 Q3 | 2.79 Million CAD | -72.11% |
| 2023 Q2 | 9.28 Million CAD | 36.83% |
| 2023 Q4 | 9.94 Million CAD | 31.66% |
| 2023 Q3 | 7.55 Million CAD | -18.71% |
| 2023 FY | 9.94 Million CAD | 36.08% |
| 2023 Q1 | 6.78 Million CAD | -7.07% |
| 2022 Q3 | 8.95 Million CAD | -6.66% |
| 2022 FY | 7.3 Million CAD | -38.58% |
| 2022 Q1 | 9.48 Million CAD | -20.26% |
| 2022 Q4 | 7.3 Million CAD | -18.45% |
| 2022 Q2 | 9.59 Million CAD | 1.18% |
| 2021 Q1 | 9.97 Million CAD | -2.61% |
| 2021 Q3 | 11.33 Million CAD | 6.04% |
| 2021 FY | 11.89 Million CAD | 16.16% |
| 2021 Q2 | 10.68 Million CAD | 7.16% |
| 2021 Q4 | 11.89 Million CAD | 4.97% |
| 2020 Q1 | 11.81 Million CAD | -1.06% |
| 2020 FY | 10.23 Million CAD | -14.26% |
| 2020 Q4 | 10.23 Million CAD | 0.51% |
| 2020 Q3 | 10.18 Million CAD | 1.75% |
| 2020 Q2 | 10.01 Million CAD | -15.27% |
| 2019 Q2 | 5.57 Million CAD | -16.02% |
| 2019 Q1 | 6.63 Million CAD | -10.09% |
| 2019 Q4 | 11.94 Million CAD | 52.91% |
| 2019 FY | 11.94 Million CAD | 122.08% |
| 2019 Q3 | 7.8 Million CAD | 40.09% |
| 2018 Q1 | 3.66 Million CAD | 21.07% |
| 2018 Q4 | 7.38 Million CAD | 37.3% |
| 2018 FY | 5.37 Million CAD | 124.33% |
| 2018 Q3 | 5.37 Million CAD | 0.25% |
| 2018 Q2 | 5.36 Million CAD | 46.45% |
| 2017 Q3 | 2.39 Million CAD | -18.24% |
| 2017 Q1 | 1.47 Million CAD | -33.43% |
| 2017 FY | 2.39 Million CAD | 8.96% |
| 2017 Q4 | 3.02 Million CAD | 26.2% |
| 2017 Q2 | 2.93 Million CAD | 98.61% |
| 2016 Q3 | 2.19 Million CAD | 1897.58% |
| 2016 Q1 | 356.01 Thousand CAD | 542.89% |
| 2016 Q4 | 2.21 Million CAD | 0.8% |
| 2016 Q2 | 110.13 Thousand CAD | -69.07% |
| 2016 FY | 2.19 Million CAD | 301.0% |
| 2015 Q2 | 59.5 Thousand CAD | 50.49% |
| 2015 Q1 | 39.54 Thousand CAD | 128.92% |
| 2015 FY | 548.62 Thousand CAD | 1287.47% |
| 2015 Q4 | 55.37 Thousand CAD | -13.28% |
| 2015 Q3 | 63.85 Thousand CAD | 7.31% |
| 2014 Q4 | 17.27 Thousand CAD | -29.94% |
| 2014 FY | 39.54 Thousand CAD | -3.94% |
| 2014 Q3 | 24.65 Thousand CAD | -57.54% |
| 2014 Q2 | 58.06 Thousand CAD | 41.05% |
| 2014 Q1 | 41.16 Thousand CAD | 5045.5% |
| 2013 Q2 | 66.85 Thousand CAD | 7.56% |
| 2013 Q3 | 12.68 Thousand CAD | -81.03% |
| 2013 Q4 | 800.00 CAD | -93.69% |
| 2013 FY | 41.16 Thousand CAD | -33.77% |
| 2013 Q1 | 62.15 Thousand CAD | 19.55% |
| 2012 Q4 | 51.99 Thousand CAD | -29.34% |
| 2012 FY | 62.15 Thousand CAD | -51.83% |
| 2012 Q2 | 71.5 Thousand CAD | -44.59% |
| 2012 Q1 | 129.04 Thousand CAD | 190.18% |
| 2012 Q3 | 73.58 Thousand CAD | 2.91% |
| 2011 Q1 | 13.87 Thousand CAD | -45.81% |
| 2011 Q4 | 44.47 Thousand CAD | -8.22% |
| 2011 Q3 | 48.45 Thousand CAD | 100.82% |
| 2011 Q2 | 24.12 Thousand CAD | 73.85% |
| 2011 FY | 129.04 Thousand CAD | 829.85% |
| 2010 Q1 | 259.88 Thousand CAD | -21.15% |
| 2010 Q3 | 32.51 Thousand CAD | -62.85% |
| 2010 Q4 | 25.61 Thousand CAD | -21.23% |
| 2010 FY | 13.87 Thousand CAD | -94.66% |
| 2010 Q2 | 87.53 Thousand CAD | -66.32% |
| 2009 Q1 | 163.44 Thousand CAD | 0.0% |
| 2009 Q4 | 329.59 Thousand CAD | 0.0% |
| 2009 FY | 259.88 Thousand CAD | 59.01% |
| 2008 FY | 163.44 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 5.38 Million CAD | -84.769% |
| CanadaBis Capital Inc. | 15.61 Million CAD | 36.355% |
| Decibel Cannabis Company Inc. | 96.79 Million CAD | 89.73% |
| Delivra Health Brands Inc. | 4.85 Million CAD | -104.625% |
| Entourage Health Corp. | 178.68 Million CAD | 94.437% |
| Cannara Biotech Inc. | 61.77 Million CAD | 83.909% |
| Medicure Inc. | 8.16 Million CAD | -21.777% |
| PharmaCielo Ltd. | 23.96 Million CAD | 58.527% |
| Rubicon Organics Inc. | 16.99 Million CAD | 41.514% |
| BioSyent Inc. | 6.76 Million CAD | -46.852% |
| Voyageur Pharmaceuticals Ltd. | 727.87 Thousand CAD | -1265.709% |